Table of contents
December 2011, Volume 29 No 12 pp1055-1150
- In This Issue
- Editorial
- News
- Bioentrepreneur
- Opinion and Comment
- Features
- News and Views
- Research Highlights
- Computational Biology
- Research
- Careers and Recruitment
In This Issue
In this issue - ppvii - viii
doi:10.1038/nbt.2068
Editorial
Tilting toward secrecy - p1055
doi:10.1038/nbt.2075
A European high court ruling on the patentability of inventions related to human embryonic stem cells could promote secrecy and reduce access to data and cell lines.
Abstract - | Full Text - Tilting toward secrecy | PDF (107 KB) - Tilting toward secrecy
News
European court bans embryonic stem cell patents - pp1057 - 1059
Nuala Moran
doi:10.1038/nbt1211-1057
Full Text - European court bans embryonic stem cell patents | PDF (348 KB) - European court bans embryonic stem cell patents
Conflicts of interest go online - p1058
Gunjan Sinha
doi:10.1038/nbt1211-1058
Full Text - Conflicts of interest go online | PDF (100 KB) - Conflicts of interest go online
Shutdown by auction - p1060
Brian Orelli
doi:10.1038/nbt1211-1060a
Full Text - Shutdown by auction | PDF (204 KB) - Shutdown by auction
GlaxoSmithKline malaria vaccine phase 3 trial heralded - pp1060 - 1062
Simon Franz
doi:10.1038/nbt1211-1060b
Full Text - GlaxoSmithKline malaria vaccine phase 3 trial heralded | PDF (293 KB) - GlaxoSmithKline malaria vaccine phase 3 trial heralded
Interest groups jostle to influence PDUFA V - p1062
Jeffrey L Fox
doi:10.1038/nbt1211-1062
Full Text - Interest groups jostle to influence PDUFA V | PDF (111 KB) - Interest groups jostle to influence PDUFA V
Industry continues dabbling with open innovation models - pp1063 - 1065
Cormac Sheridan
doi:10.1038/nbt1211-1063a
Full Text - Industry continues dabbling with open innovation models | PDF (1,255 KB) - Industry continues dabbling with open innovation models
Cold-tolerant trees win - p1063
Emily Walt
doi:10.1038/nbt1211-1063b
Full Text - Cold-tolerant trees win | PDF (325 KB) - Cold-tolerant trees win
Around the world in a month - p1065
doi:10.1038/nbt1211-1065
Full Text - Around the world in a month | PDF (1,614 KB) - Around the world in a month
Jackson's $1.1 billion makeover - p1066
Jennifer Rohn
doi:10.1038/nbt1211-1066a
Full Text - Jackson's $1.1 billion makeover | PDF (74 KB) - Jackson's $1.1 billion makeover
Near-record drug approvals - p1066
Jeffrey L. Fox
doi:10.1038/nbt1211-1066b
Full Text - Near-record drug approvals | PDF (74 KB) - Near-record drug approvals
New startup models emerge as investor landscape shifts - pp1066 - 1067
Brady Huggett
doi:10.1038/nbt1211-1066c
Full Text - New startup models emerge as investor landscape shifts | PDF (134 KB) - New startup models emerge as investor landscape shifts
Newsmaker
Zafgen - p1068
Jennifer Rohn
doi:10.1038/nbt1211-1068
Zafgen hopes that small-molecule targeting of methionine aminopeptidase 2 (MetAP2), an enzyme originally associated with tumor angiogenesis, will lead to a new anti-obesity drug.
Bioentrepreneur
Shape shifting - pp1069 - 1071
Bob Baltera
doi:10.1038/nbt.2034
Faced with limited funding and the need to find the most time- and cost-efficient route to proof of concept and relevance, how should you reorganize your company to facilitate development of your most valuable assets?
Opinion and Comment
Correspondence
Generation of the potent anti-malarial drug artemisinin in tobacco - pp1072 - 1074
Moran Farhi, Elena Marhevka, Julius Ben-Ari, Anna Algamas-Dimantov, Zhuobin Liang, Vardit Zeevi, Orit Edelbaum, Ben Spitzer-Rimon, Hagai Abeliovich, Betty Schwartz, Tzvi Tzfira & Alexander Vainstein
doi:10.1038/nbt.2054
Full Text - Generation of the potent anti-malarial drug artemisinin in tobacco | PDF (410 KB) - Generation of the potent anti-malarial drug artemisinin in tobacco | Supplementary information
Relative potential of biosynthetic pathways for biofuels and bio-based products - pp1074 - 1078
Deepak Dugar & Gregory Stephanopoulos
doi:10.1038/nbt.2055
Full Text - Relative potential of biosynthetic pathways for biofuels and bio-based products | PDF (346 KB) - Relative potential of biosynthetic pathways for biofuels and bio-based products | Supplementary information
Re-evaluating PARP1 inhibitor in cancer - pp1078 - 1079
Alexei Tulin
doi:10.1038/nbt.2058
Full Text - Re-evaluating PARP1 inhibitor in cancer | PDF (293 KB) - Re-evaluating PARP1 inhibitor in cancer
Access to human embryonic stem cell lines - pp1079 - 1081
Aaron D Levine
doi:10.1038/nbt.2029
Full Text - Access to human embryonic stem cell lines | PDF (285 KB) - Access to human embryonic stem cell lines | Supplementary information
Sarbanes-Oxley overburdens biotech companies - pp1081 - 1082
Mark Kessel
doi:10.1038/nbt.2059
Full Text - Sarbanes-Oxley overburdens biotech companies | PDF (166 KB) - Sarbanes-Oxley overburdens biotech companies
Features
What's fueling the biotech engine—2010 to 2011 - pp1083 - 1089
Saurabh Aggarwal
doi:10.1038/nbt.2060
In the past year, biologics sector sales grew by single digits, driven by monoclonal antibodies and insulin products. New product launches are showing mixed results and are facing rising challenges from changes to reimbursement policies.
Abstract - | Full Text - What's fueling the biotech engine—2010 to 2011 | PDF (712 KB) - What's fueling the biotech engine—2010 to 2011
Patents
Agricultural microbial resources: private property or global commons? - pp1091 - 1093
David Kothamasi, Matthew Spurlock & E Toby Kiers
doi:10.1038/nbt.2056
Agricultural microbes have become an attractive target for patenting, but the lack of a consistent global patent regime and increasingly heated debates over microbial ownership rights are barriers to the development of this resource.
Abstract - | Full Text - Agricultural microbial resources: private property or global commons? | PDF (152 KB) - Agricultural microbial resources: private property or global commons?
Recent patent applications related to agricultural microbes - p1094
doi:10.1038/nbt.2066
Full Text - Recent patent applications related to agricultural microbes | PDF (48 KB) - Recent patent applications related to agricultural microbes
News and Views
Dissecting cancer heterogeneity - pp1095 - 1096
David Dornan & Jeff Settleman
doi:10.1038/nbt.2063
Transcriptional profiling of single cells in colon tumors may enable prediction of patient outcomes.
Full Text - Dissecting cancer heterogeneity | PDF (1,011 KB) - Dissecting cancer heterogeneity
See also: Research by Dalerba et al.
Genomic rearrangement in three dimensions - pp1096 - 1098
PJ Hastings & Susan M Rosenberg
doi:10.1038/nbt.2064
Two studies illuminate why genome rearrangements in cancer cells occur where they do.
Full Text - Genomic rearrangement in three dimensions | PDF (206 KB) - Genomic rearrangement in three dimensions
See also: Computational Biology by De & Michor | Computational Biology by Fudenberg et al.
The new landscape of protein ubiquitination - pp1098 - 1100
Guoqiang Xu & Samie R Jaffrey
doi:10.1038/nbt.2061
Proteome-wide identification of ubiquitination events reveals their functional classes and identifies substrates for ubiquitin ligases.
Full Text - The new landscape of protein ubiquitination | PDF (856 KB) - The new landscape of protein ubiquitination
Research Highlights
Two antibodies for the price of one
Multigenome analysis of variation
Ribosomes reveal proteome complexity
Sifting proteins for proteomics
New role for VEGF
Computational Biology
Analysis
DNA replication timing and long-range DNA interactions predict mutational landscapes of cancer genomes - pp1103 - 1108
Subhajyoti De & Franziska Michor
doi:10.1038/nbt.2030
Copy-number changes in cancer genomes may be caused by errors during the replication of colocalized DNA regions. De and Michor provide genome-wide evidence for this model by integrating data on DNA replication timing, the three-dimensional organization of the genome and copy-number alterations in cancer.
Abstract - | Full Text - DNA replication timing and long-range DNA interactions predict mutational landscapes of cancer genomes | PDF (778 KB) - DNA replication timing and long-range DNA interactions predict mutational landscapes of cancer genomes | Supplementary information
See also: News and Views by Hastings & Rosenberg
High order chromatin architecture shapes the landscape of chromosomal alterations in cancer - pp1109 - 1113
Geoff Fudenberg, Gad Getz, Matthew Meyerson & Leonid A Mirny
doi:10.1038/nbt.2049
Copy-number changes, point mutations and rearrangements are all usually found in cancer genomes, but their relative frequencies are highly variable. Using statistical approaches to model different processes, Fudenberg et al. find that copy number gain and loss is influenced by the three-dimensional organization of the genome in the nucleus.
Abstract - | Full Text - High order chromatin architecture shapes the landscape of chromosomal alterations in cancer | PDF (628 KB) - High order chromatin architecture shapes the landscape of chromosomal alterations in cancer | Supplementary information
See also: News and Views by Hastings & Rosenberg
Research
Brief Communications
In silico feedback for in vivo regulation of a gene expression circuit - pp1114 - 1116
Andreas Milias-Argeitis, Sean Summers, Jacob Stewart-Ornstein, Ignacio Zuleta, David Pincus, Hana El-Samad, Mustafa Khammash & John Lygeros
doi:10.1038/nbt.2018
Creating synthetic biological circuits can be maddeningly difficult because of unpredictable stimuli and unknown variability in the system. Milias-Argeitis et al. circumvent these problems by moving control functions outside the cell—to a computer—and connecting computer and cell through optogenetics.
Abstract - | Full Text - In silico feedback for in vivo regulation of a gene expression circuit | PDF (303 KB) - In silico feedback for in vivo regulation of a gene expression circuit | Supplementary information
Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells - pp1117 - 1119
Kitai Kim, Rui Zhao, Akiko Doi, Kitwa Ng, Juli Unternaehrer, Patrick Cahan, Huo Hongguang, Yuin-Han Loh, Martin J Aryee, M William Lensch, Hu Li, James J Collins, Andrew P Feinberg & George Q Daley
doi:10.1038/nbt.2052
Mouse induced pluripotent stem (iPS) cells have been shown to retain an epigenetic 'memory' of their cell type of origin. Kim et al. study this question in human cells and document both incomplete erasure of methylation and aberrant de novo methylation during reprogramming.
Abstract - | Full Text - Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells | PDF (357 KB) - Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells | Supplementary information
Article
Single-cell dissection of transcriptional heterogeneity in human colon tumors - pp1120 - 1127
Piero Dalerba, Tomer Kalisky, Debashis Sahoo, Pradeep S Rajendran, Michael E Rothenberg, Anne A Leyrat, Sopheak Sim, Jennifer Okamoto, Darius M Johnston, Dalong Qian, Maider Zabala, Janet Bueno, Norma F Neff, Jianbin Wang, Andrew A Shelton, Brendan Visser, Shigeo Hisamori, Yohei Shimono, Marc van de Wetering, Hans Clevers, Michael F Clarke & Stephen R Quake
doi:10.1038/nbt.2038
Not all cells in a tumor are alike, but our ability to characterize cancer heterogeneity in detail has been limited. Dalerba et al. use high-throughput single-cell expression analysis to define clinically relevant subpopulations in normal and cancerous colon tissue.
Abstract - | Full Text - Single-cell dissection of transcriptional heterogeneity in human colon tumors | PDF (2,704 KB) - Single-cell dissection of transcriptional heterogeneity in human colon tumors | Supplementary information
See also: News and Views by Dornan & Settleman
Letter
Efficacy of genetically modified Bt toxins against insects with different genetic mechanisms of resistance - pp1128 - 1131
Bruce E Tabashnik, Fangneng Huang, Mukti N Ghimire, B Rogers Leonard, Blair D Siegfried, Murugesan Rangasamy, Yajun Yang, Yidong Wu, Linda J Gahan, David G Heckel, Alejandra Bravo & Mario Soberón
doi:10.1038/nbt.1988
The benefits of crops that produce insecticidal toxins from Bacillus thuringiensis (Bt) are threatened by the emergence of insect resistance. Working with five major crop pests, Tabashnik et al. show that previously described variant Bt toxins kill pests rendered resistant to native Bt toxins by multiple mechanisms.
First Paragraph - | Full Text - Efficacy of genetically modified Bt toxins against insects with different genetic mechanisms of resistance | PDF (448 KB) - Efficacy of genetically modified Bt toxins against insects with different genetic mechanisms of resistance | Supplementary information
Resources
Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage - pp1132 - 1144
Katherine Amps, Peter W Andrews, George Anyfantis, Lyle Armstrong, Stuart Avery, Hossein Baharvand, Julie Baker, Duncan Baker, Maria B Munoz, Stephen Beil, Nissim Benvenisty, Dalit Ben-Yosef, Juan-Carlos Biancotti, Alexis Bosman, Romulo Martin Brena, Daniel Brison, Gunilla Caisander, María V Camarasa, Jieming Chen, Eric Chiao, Young Min Choi, Andre B H Choo, Daniel Collins, Alan Colman, Jeremy M Crook, George Q Daley, Anne Dalton, Paul A De Sousa, Chris Denning, Janet Downie, Petr Dvorak, Karen D Montgomery, Anis Feki, Angela Ford, Victoria Fox, Ana M Fraga, Tzvia Frumkin, Lin Ge, Paul J Gokhale, Tamar Golan-Lev, Hamid Gourabi, Michal Gropp, Lu Guangxiu, Ales Hampl, Katie Harron, Lyn Healy, Wishva Herath, Frida Holm, Outi Hovatta, Johan Hyllner, Maneesha S Inamdar, Astrid Kresentia Irwanto, Tetsuya Ishii, Marisa Jaconi, Ying Jin, Susan Kimber, Sergey Kiselev, Barbara B Knowles, Oded Kopper, Valeri Kukharenko, Anver Kuliev, Maria A Lagarkova, Peter W Laird, Majlinda Lako, Andrew L Laslett, Neta Lavon, Dong Ryul Lee, Jeoung Eun Lee, Chunliang Li, Linda S Lim, Tenneille E Ludwig, Yu Ma, Edna Maltby, Ileana Mateizel, Yoav Mayshar, Maria Mileikovsky, Stephen L Minger, Takamichi Miyazaki, Shin Yong Moon, Harry Moore, Christine Mummery, Andras Nagy, Norio Nakatsuji, Kavita Narwani, Steve K W Oh, Sun Kyung Oh, Cia Olson, Timo Otonkoski, Fei Pan, In-Hyun Park, Steve Pells, Martin F Pera, Lygia V Pereira, Ouyang Qi, Grace Selva Raj, Benjamin Reubinoff, Alan Robins, Paul Robson, Janet Rossant, Ghasem H Salekdeh, Thomas C Schulz, Karen Sermon, Jameelah Sheik Mohamed, Hui Shen, Eric Sherrer, Kuldip Sidhu, Shirani Sivarajah, Heli Skottman, Claudia Spits, Glyn N Stacey, Raimund Strehl, Nick Strelchenko, Hirofumi Suemori, Bowen Sun, Riitta Suuronen, Kazutoshi Takahashi, Timo Tuuri, Parvathy Venu, Yuri Verlinsky, Dorien Ward-van Oostwaard, Daniel J Weisenberger, Yue Wu, Shinya Yamanaka, Lorraine Young, Qi Zhou & The International Stem Cell Initiative
doi:10.1038/nbt.2051
The International Stem Cell Initiative compares 125 ethnically diverse human embryonic stem cell lines at early and late passage. Data on karotype, single-nucleotide polymorphisms and methylation shed light on how the cells adapt to long-term culture.
Abstract - | Full Text - Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage | PDF (1,173 KB) - Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage | Supplementary information
Careers and Recruitment
The challenges of modern interdisciplinary medical research - pp1145 - 1148
Philipp von Roth, Benedict J Canny, Hans-Dieter Volk, J Alison Noble, Charles G Prober, Carsten Perka & Georg N Duda
doi:10.1038/nbt.2062
The increasing complexity of medical science poses significant challenges to medical education, leading to a growing gap between medical researchers and treating practitioners.
Abstract - | Full Text - The challenges of modern interdisciplinary medical research | PDF (232 KB) - The challenges of modern interdisciplinary medical research